Decreased dopamine levels correlated with the development of colitis in both humans and rodents, and rodent studies showed that dopamine signaling through D5-mediated changes in macrophage phenotype that decreased inflammation (Magro et al., 2004; Liu, Wu et al., 2021). Here, MAB21L3 is linked to colitis.